Moreover, the single-cell sequencing of bevacizumab-resistant patient glioblastomas confirmed up-regulated mesenchymal genes, particularly glycoprotein YKL-40 and transcription factor ZEB1, in later clones, implicating these changes as treatment-induced. The gene discussed is ZEB1; the disease is glioblastoma.